T2014-001: A Phase I Trial of Temsirolimus (CCI-779, Pfizer, Inc.) in Combination with Etoposide and Cyclophosphamide in Children with Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

      Project: Research project

      Project Details

      StatusFinished
      Effective start/end date4/1/163/31/20

      Funding

      • Children's Hospital of Los Angeles